$570 Million is the total value of Avoro Capital Advisors LLC's 48 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 47.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SRPT | Sell | SAREPTA THERAPUTICS INC | $84,126,000 | +212.4% | 1,369,909 | -3.0% | 14.76% | +146.7% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $38,832,000 | +15.3% | 419,712 | -3.1% | 6.81% | -9.0% |
| LBIO | Sell | LION BIOTECHNOLOGIES INC | $35,038,000 | -0.3% | 4,257,347 | -1.9% | 6.15% | -21.3% |
| TSRO | Sell | TESARO INC | $27,837,000 | -35.6% | 277,703 | -46.0% | 4.88% | -49.1% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $27,305,000 | +35.2% | 3,689,857 | -0.2% | 4.79% | +6.8% |
| DERM | Buy | DERMIRA INC | $27,256,000 | +29.1% | 805,926 | +11.7% | 4.78% | +2.0% |
| AGEN | Buy | AGENUS INC | $26,680,000 | +112.5% | 3,715,938 | +19.9% | 4.68% | +67.8% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $25,209,000 | +135.7% | 792,499 | +140.5% | 4.42% | +86.1% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $24,843,000 | +7.3% | 490,582 | -3.7% | 4.36% | -15.3% |
| IMMU | Sell | IMMUNOMEDICS INC | $23,869,000 | +20.2% | 7,344,177 | -14.2% | 4.19% | -5.1% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO. | $21,561,000 | -34.2% | 399,875 | -10.2% | 3.78% | -48.0% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS | $20,037,000 | +25.3% | 869,263 | -9.8% | 3.52% | -1.0% |
| AERI | New | AERIE PHARMACEUTICALS INC | $18,870,000 | – | 500,000 | +100.0% | 3.31% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $17,733,000 | – | 133,600 | +100.0% | 3.11% | – |
| VNDA | Buy | VANDA PHARMACEUTICALS INC | $13,773,000 | +73.5% | 827,693 | +16.6% | 2.42% | +37.0% |
| Buy | NEURODERM LTD | $12,690,000 | +40.2% | 686,303 | +23.2% | 2.23% | +10.7% | |
| TLGT | Buy | TELIGENT INC | $12,447,000 | +35.1% | 1,637,819 | +27.0% | 2.18% | +6.7% |
| SRNE | Sell | SORRENTO THERAPEUTICS INC | $11,852,000 | +27.9% | 1,531,273 | -7.5% | 2.08% | +1.0% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $9,839,000 | +48.3% | 1,488,487 | +22.5% | 1.73% | +17.1% |
| CASC | Sell | CASCADIAN THERAPEUTICS INC | $9,203,000 | +69.9% | 5,611,323 | -2.3% | 1.62% | +34.1% |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $8,548,000 | +83.7% | 944,579 | +51.9% | 1.50% | +45.1% |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $7,923,000 | – | 150,000 | +100.0% | 1.39% | – |
| SGEN | New | SEATTLE GENETICS INC | $7,642,000 | – | 141,500 | +100.0% | 1.34% | – |
| VCYT | VERACYTE INC | $6,990,000 | +51.3% | 918,556 | 0.0% | 1.23% | +19.5% | |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $6,083,000 | – | 1,379,402 | +100.0% | 1.07% | – |
| SRPT | Sell | SAREPTA THERAPUTICS INCcall | $6,033,000 | +131.8% | 190,000 | -69.6% | 1.06% | +83.2% |
| ALIM | New | ALIMERA SCIENCES INC | $5,327,000 | – | 3,575,000 | +100.0% | 0.94% | – |
| Buy | TRILLIUM THERAPEUTICS INC | $4,671,000 | +127.4% | 316,020 | +38.2% | 0.82% | +79.8% | |
| CRVS | Buy | CORVUS PHARMACEUTICALS INC | $4,415,000 | +313.8% | 268,369 | +258.8% | 0.78% | +227.0% |
| FBIO | Buy | FORTRESS BIOTECH INC | $4,029,000 | +12.9% | 1,356,636 | +2.3% | 0.71% | -10.8% |
| PTI | New | PROTEOSTASIS THERAPEUTICS INC | $2,799,000 | – | 179,565 | +100.0% | 0.49% | – |
| INNL | INNOCOLL HOLDINGS PLCshares | $2,720,000 | +5.5% | 468,148 | 0.0% | 0.48% | -16.8% | |
| PERNIX THERAPEUTICS HOLDINGS INCconvertible debt | $2,050,000 | +37.9% | 7,000,000 | 0.0% | 0.36% | +9.1% | ||
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $1,933,000 | +33.5% | 268,119 | +2.7% | 0.34% | +5.3% |
| ONS | Sell | ONCOBIOLOGICS INC | $1,916,000 | +20.7% | 450,872 | -3.4% | 0.34% | -4.8% |
| CLLS | Buy | CELLECTIS - ADRsponsored adr | $1,413,000 | +24.5% | 58,671 | +37.5% | 0.25% | -1.6% |
| VSAR | New | VERSARTIS INC | $1,173,000 | – | 95,742 | +100.0% | 0.21% | – |
| OMED | New | ONCOMED PHARMACEUTICALS INC | $972,000 | – | 85,000 | +100.0% | 0.17% | – |
| ASND | New | ASCENDIS PHARMAsponsored adr | $909,000 | – | 45,203 | +100.0% | 0.16% | – |
| AGEN | New | AGENUS INCcall | $800,000 | – | 1,000,000 | +100.0% | 0.14% | – |
| CEMP | New | CEMPRA INC | $726,000 | – | 30,000 | +100.0% | 0.13% | – |
| VCEL | Sell | VERICEL CORP | $604,000 | +5.2% | 215,744 | -15.4% | 0.11% | -17.2% |
| NK | NANTKWEST INC | $563,000 | +25.1% | 72,412 | 0.0% | 0.10% | -1.0% | |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $271,000 | – | 46,082 | +100.0% | 0.05% | – |
| ONSIZ | ONCOBIOLOGICS INC - WARRANT Bwarrant | $233,000 | +121.9% | 233,333 | 0.0% | 0.04% | +78.3% | |
| ONSIW | ONCOBIOLOGICS INC - WARRANT Awarrant | $112,000 | +4.7% | 233,333 | 0.0% | 0.02% | -16.7% | |
| IMMU | Sell | IMMUNOMEDICS INCcall | $53,000 | -17.2% | 300,800 | -33.7% | 0.01% | -35.7% |
| SRPT | Sell | SAREPTA THERAPUTICS INCput | $2,000 | -99.9% | 75,600 | -94.3% | 0.00% | -100.0% |
| Exit | ISh RUSSELL 2000 ETFput | $0 | – | -50,000 | -100.0% | -0.00% | – | |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -70,000 | -100.0% | -0.25% | – |
| CYTK | Exit | CYTOKINETICS INC. | $0 | – | -503,900 | -100.0% | -1.06% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -108,500 | -100.0% | -2.01% | – |
| RLYP | Exit | RELYPSA INC | $0 | – | -613,300 | -100.0% | -2.52% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -279,700 | -100.0% | -3.75% | – |
| CPXX | Exit | CELATOR PHARMACEUTICALS INC. | $0 | – | -1,124,666 | -100.0% | -7.54% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 36 | Q3 2023 | 17.9% |
| MIRATI THERAPEUTICS INC. | 35 | Q3 2023 | 17.2% |
| BIOMARIN PHARMACEUTICAL INC | 31 | Q3 2023 | 8.0% |
| SAREPTA THERAPUTICS INC | 28 | Q3 2023 | 14.8% |
| ASCENDIS PHARMA | 28 | Q3 2023 | 9.1% |
| ARGENX SE | 26 | Q3 2023 | 9.5% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
| FENNEC PHARMACEUTICALS INC | 25 | Q3 2023 | 0.4% |
| MADRIGAL PHARMACEUTICALS INC | 22 | Q3 2023 | 7.2% |
| XENON PHARMACEUTICALS INC | 22 | Q3 2023 | 3.3% |
View Avoro Capital Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| DICE Therapeutics, Inc. | February 14, 2023 | 2,525,555 | 5.3% |
| IOVANCE BIOTHERAPEUTICS, INC. | February 14, 2023 | 7,020,000 | 4.4% |
| IVERIC bio, Inc. | February 14, 2023 | 6,750,000 | 5.0% |
| Kura Oncology, Inc. | February 14, 2023 | 3,105,000 | 4.5% |
| Aadi Bioscience, Inc. | September 26, 2022 | 2,849,402 | 11.7% |
| ARENA PHARMACEUTICALS INC | February 11, 2022 | 1,235,000 | 2.0% |
| AVADEL PHARMACEUTICALS PLC | February 11, 2022 | 1,670,000 | 2.9% |
| FENNEC PHARMACEUTICALS INC. | February 11, 2022 | 1,200,000 | 4.6% |
| POINT Biopharma Global Inc.Sold out | February 11, 2022 | 0 | 0.0% |
View Avoro Capital Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-23 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Avoro Capital Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.